AbbVie (ABBV) Price to Earnings (2013 - 2026)
AbbVie's (ABBV) Price to Earnings came in at 70.47 for Q2 2026, down 19.1% from 87.14 a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Price to Earnings (2013 - 2026) Analysis & Trends
For FY2025, AbbVie's Price to Earnings stood at 95.60, up 30.4% from FY2024.
- Annual Price to Earnings has increased for four consecutive years.
- In prior years, AbbVie's Price to Earnings was 73.33 in FY2024 (+30.3%), 56.29 in FY2023 (+133.0%), 24.16 in FY2022 (+16.4%) and 20.75 in FY2021 (-49.4%).
- The Q2 2026 figure stands as the lowest quarterly Price to Earnings since Q3 2024.
- On a year-over-year basis, Price to Earnings increased in seven of the last eight quarters, with growth averaging 49.9%.
- The strongest year-over-year quarter for Price to Earnings in the past five years was Q3 2025, with growth of 151.5%; the weakest was Q4 2021, with a decline of 49.4%.
- According to Business Quant data, Price to Earnings for the three prior quarters was 105.71 (Q1 2026), 95.60 (Q4 2025) and 171.37 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.47 |
| Mar 31, 2026 | 105.71 |
| Dec 31, 2025 | 95.60 |
| Sep 30, 2025 | 171.37 |
| Jun 30, 2025 | 87.14 |
| Mar 31, 2025 | 88.22 |
| Dec 31, 2024 | 73.33 |
| Sep 30, 2024 | 68.13 |
| Jun 30, 2024 | 56.75 |
| Mar 31, 2024 | 53.66 |
| Dec 31, 2023 | 56.29 |
| Sep 30, 2023 | 40.40 |
| Jun 30, 2023 | 27.38 |
| Mar 31, 2023 | 37.07 |
| Dec 31, 2022 | 24.16 |
| Sep 30, 2022 | 17.70 |
| Jun 30, 2022 | 21.43 |
| Mar 31, 2022 | 22.96 |
| Dec 31, 2021 | 20.75 |
| Sep 30, 2021 | 25.31 |
API Access
AbbVie Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();